Caris Life Sciences IPO Prices Above Range to Raise $494 Million

Caris Life Sciences IPO Prices Above Range to Raise 4 Million



Caris Life Sciences IPO Prices Above Range to Raise $494 Million
Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its marketed range.


www.bloomberg.com
#Caris #Life #Sciences #IPO #Prices #Range #Raise #Million

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *